Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

Dozens of Ozempic and Wegovy users have reported suffering from eye disorders they claim are associated with the drugs, ...

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

respectively), as well as two pertaining to Ozempic/Wegovy and one pertaining to Mounjaro ("new" medications, approved for weight loss in 2021 and 2023, respectively). Steffen Trumpf/picture ...